AAC trades as part of the health care providers industry and is part of the healthcare sector. The company CEO is Michael T. Cartwright. AAC Inc provides inpatient and outpatient substance abuse treatment services for individuals with drug and alcohol addiction. The company also performs drug testing and diagnostics laboratory services and provides physician services.
Previous Intraday Performance:
The AAC shares had a previous change of -15.39% which opened at 1.29 and closed at 1.10. It moved to an intraday high of 1.31 and a low of 1.05.
PR Newswire: Desert Hope Treatment Center Welcomes Dee Wirth as Alumni Manager
Historical Performance:
Over the last five trading days, AAC shares returned -20.86% and in the past 30 trading days it returned -47.37%. Over three months, it changed -64.74%. In one year it has changed -91.08% and within that year its 52 week high was 11.63 and its 52 week low was 1.05. AAC stock is 4.76% above its 52 week low.
Our calculations result in a 200 day moving average of 4.00 and a 50 day moving average of 1.82. Right now, AAC stock is trading -72.47% below its 200 day moving average and may not be a great opportunity to buy as it may continue to trend down.
PR Newswire: Desert Hope Treatment Center Welcomes Dee Wirth as Alumni Manager
Liquidity:
The company has a market cap of $27.8m with 25.3m shares outstanding and a float of 9.4m shares. Trading volume was 813,940 shares and has experienced an average volume of 325,279 shares. Our calculation, using the current average volume and close price, leads me to believe that the liquidity is bad, highly speculative and an investor may want to avoid this stock.
Earnings:
The last annual reported EPS for AAC was -2.41 which ended on 31st of December 2018. Based on 2 analyst estimates, the consensus EPS for the next quarter is 0.00.
Below was the last reported quarterly diluted earnings per share:
| 1st | Qtr 2019 | -0.90 |
|---|---|---|
| 4th | Qtr 2018 | -1.51 |
| 3rd | Qtr 2018 | -0.47 |
| 2nd | Qtr 2018 | -0.12 |
| 1st | Qtr 2018 | 0.04 |
Base on our calculations, the intrinsic value per share is 4.84, which means it might be undervalued and has a margin of safety of 77.28%.
The long-term trend of the EPS is a vital number as it helps understand the future potential of AAC; it is usually expressed as a percentage and is then referred to as the EPS growth rate, which at this time is hard to estimate, but revenue growth has been -19.10% over the last twelve months.
Indicators Also to Watch:
Based on the latest filings, there is 59.10% of institutional ownership. Short-interest was 3,911,037, which was 15.46% of shares outstanding. The short-interest ratio or days-to-cover ratio was 16.26. This stock has a moderate level of short interest, but may still be a buying opportunity depending on other indicators.
The beta was calculated to be 2.44.
Fundamental Numbers:
Based on last reported financials, the company’s return on equity is -88.65%, return on assets is -17.30%, profit margin is -33.64%, price-to-sales is 0.11 and price-to-book is 0.65.
Company Score Card:
Results are out of six:
3 : Growth Expectations Result
0 : Financial Safety Result
0 : Past Performance Result
3 : Valuation Result
0 : Dividend Safety Result
1 : Overall Result
Related Tags: AAC, Health Care Providers, Healthcare
